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Two equine influenza virus (EIV) strains were isolated during two restricted 
outbreaks from Heilongjiang Province, China in 2010 and 2011. Phylogenetic 
analysis of HA1 (hemagglutinin 1) gene revealed that the isolates belonged to 
Florida 2 sublineage of American lineage. Further analysis of the putative antigenic 
sites located in HA1 subunit protein revealed each isolate had a unique amino acid 
change. Analysis of antigenic sites between Chinese EIV and vaccine strains 
indicated equine influenza (EI) vaccines containing Richmond/1/07-like antigen 
seemed to have an optimum effect in China. Meanwhile, the Ohio/03 vaccine strain 
contained in updated ProteqFlu had the most closely genetically relationship with 
recent EIV isolates in China. China has not its own commercially available EI 
vaccine and most horses are still unvaccinated. Therefore, to monitor antigenic 
variation of circulating EIVs and give considerable suggestions on selection of 
vaccine candidate plays an important role in preventing and controlling EIV in 
China. 
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INTRODUCTION 
 
Equine influenza virus (EIV), belonging to the 
orthomyxoviridae family, is generally associated with 
severe acute respiratory disease in horses. Until now, two 
subtypes of EIV, H7N7 and H3N8, are responsible as 
notifiable horse disease of EI listed by the World 
Organization for Animal Health (OIE). H7N7 subtype 
EIV has not been isolated for nearly 30 years in horse 
populations all over the world. Meanwhile, antigenic drift 
has given rise to the diversity of H3N8 subtype EIV with 
a worldwide distribution. The H3N8 virus diverged into 
two antigenically and genetically different evolutionary 
lineages since 1986: the American and the European 
lineage (Barbic et al., 2009). And the American lineage 
further evolved into the Kentucky, South American and 
Florida sublineage clades 1 and 2 (Damiani et al., 2009; 
Gildea et al., 2011b; Motoshima et al., 2011). 
Between 2007 and 2008, a serious outbreak of EI 
occurred in China. And the epizootic  mainly  occurred  in 
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Northern China, such as Heilongjiang, Liaoning, Inner 
Mongolia, Xinjiang, and Gansu, and only one was isolated  
in Hubei, in southern China. The virus responsible for the 
epizootic event is identified as Florida sublineage clade 2 
of H3N8 subtype EIV (Qi et al., 2010). Moreover, during 
this period, the majority of EIVs responsible for the large 
outbreaks in Asia belonged to the Florida sublineage, such 
as in Japan (Florida 1), Mongolia (Florida 2) and 
Australia (Florida 1).  
Vaccination can still be regarded as the most effective 
method for prevention of EI, though outbreaks of EI 
continue to infect some horse populations that have the 
extensive use of vaccines (Rozek et al., 2009). Traditional 
vaccine strategies against influenza have focused on 
inducing antibody responses against the viral surface 
glycoproteins, particularly the hemagglutinin (HA). 
Whether protection induced by one virus strain is 
effective against another relies on the antigenic 
differences between them (Mumford, 1992). Therefore, to 
monitor the antigenic variation of HA and other viral 
proteins of new emerging virus strains is important for 
OIE to make decisions for the selection of appropriate 
vaccine strains. 
SHORT COMMUNICATION Pak Vet J, 2013, 33(2): 238-240. 
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MATERIALS AND METHODS 
 
Sample, virus isolation and sequencing: Two restricted 
outbreaks in two different herds of Heilongjiang Province 
in China were observed in 2010 and 2011. The infected 
horses presented clinical sighs of cough, high fever, 
serious nasal discharge and dyspnea. Nasal swab samples 
were processed for virus isolation in 9-10-day old Specific 
Pathogen Free (SPF) embryonated chicken eggs. 
Meanwhile, viral RNA was directly extracted from the 
nasal swabs samples and subjected to RT-PCR. The full-
length HA1 gene was PCR amplified with a set of primers 
(forward: 5’-CAGAATTCATGGATTCCAACACTGTGT 
C-3’ and reverse: 5’-AACTCGAGTCA TTTCTGCTTTG 
AAGGGA-3’) designed based on the published EIV 
sequence online (http://www.ncbi.nlm.nih.gov/).  
 
Antigenic analysis: To differentiate the subtype of these 
two isolates, the collected horse sera were used in HI 
assays according to standard procedures. Viruses were 
tested against antiserums specific for American (Miami/ 
63, Xinjiang/3/07, Heilongjiang/1/2010, Heilongjiang/ 
1/2011) and European (Qinghai/94) representative 
viruses. Serums of the natural infected horses were 
obtained by our laboratory when the epidemics generated, 
including horse serums against Xinjiang/3/07, Heilongjiang 
/1/2010 and Heilongjiang/1/2011. Besides, serums of 
guinea pigs against Qinghai/94 and Miami/63 were 
collected via immunization with corresponding antigens. 
 
Genetic analysis: The HA1 sequences of Heilongjiang/ 
1/2010 and Heilongjiang/1/2011 were submitted to 
GenBank (accession Nos. JQ265982 and JQ265983). To 
analysis the genetic relationships of the two EIV isolates, 
the HA1 genes of Heilongjiang/1/10 and Heilongjiang/ 
1/11 were compared to other thirty-five sequences, 
including some EIVs isolated in China and other countries 
and vaccine isolates recommended by OIE (Newmarket/ 
1/93, Newmarket/2/93, Kentucky/1/94, Ohio/ 1/03, 
Africa/4/03 and Richmond/1/07). At last, an unrooted 
phylogenetic tree employing neighbor joining (NJ) 
bootstrap analysis was generated using MEGA 4.0. The 
statistical validity was supported by the bootstrap values 
based on 1000 replications.  
 
RESULTS AND DISCUSSION 
 
Two field EIV strains were obtained from two 
restricted outbreaks in Heilongjiang Province during 2010 
and 2012, and were designated as A/equine/ 
Heilongjiang/1/2010 and A/equine/ Heilongjiang/1/2011, 
respectively. The two strains were antigenic characterized 
by HI assay (Table 1). The results of serums of 
Heilongjiang/1/2010,  Heilongjiang/1/2011 against 
Xinjiang/3/07(256, 256) and Qinghai/94(64, 64) indicated 
b o t h  v i r u s e s  w e r e  o f  A m e r i c a n  r a t h e r  t h a n  E u r o p e a n  
lineage. Meanwhile, HI titers of Heilongjiang/1/2010, 
Heilongjiang/1/2011 against serum of Xinjiang/ 3/07 
(512,512), Qinghai/94(64,32) and Miami/63(32,16) 
suggested antigenic difference existed between them and 
field EIVs in China evolve constantly under host 
immunity pressure. Also, antigenic analysis revealed no 
much antigenic difference occurred between Heilongjiang 
/1/2010 and Heilongjiang/1/2011, but when subjected to 
Xinjiang/3/07, some antigenic difference appeared. 
 
Table 1: The results of HI titers using EIV isolates and three reference 
viruses against corresponding serums 
Serums  Viruses 
  Heilongjiang/ 
1/2011 
Heilongjiang/ 
1/2010 
Xinjiang/ 
3/07 
Qinghai/ 
94 
Miami/ 
63 
Heilongjiang/1/2011  512  512  512  32  16 
Heilongjiang/1/2010  512  512  512  64  32 
Xinjiang/3/07  256  256  1024  256  32 
Qinghai/94  64  64  256  4096  32 
Miami/63  32  32  64  128  2048 
The results of virus against homologous serums are shaded; two new 
isolates are indicated in bold. 
 
To perform phylogenetic analysis of HA1 gene of 
A/equine/Heilongjiang/2010 and A/equine/ Heilongjiang/ 
2011, a neighbor-joining phylogenetic tree was 
constructed (Fig. 1). Different from Tokyo/3/08 
responsible for the 2008 EIV epidemic in Japan belonging 
to Florida sublineage clade 1, the two newly emerging 
strains clustered in a same branch of Florida sublineage 
clade 2 with the causative strains of 07-08 EIV outbreak 
in China, such as Heilongjiang/10/08, Xinjiang/1/07, 
Hubei/6/08, Gansu/7/08, Huabei/1/07, Inner Mongolia/ 
8/08 and Mongolia1/08. Richmond/1/07 was the only one 
located in Florida sublineage clade 2 among vaccine 
strains listed by OIE.  
Comparisons of amino acid sequences of two EIV 
isolates with other H3N8 EIVs revealed both viruses were 
of Florida 2 sublineage of American lineage, showing 
more than 99% homology with Chinese isolates during 
2007-2008 (data not shown). Aligned with conserved 
HA1 gene, no deletion or insertion of amino acid 
substitutions were found in Heilongjiang/1/10 and 
Heilongjiang/1/11. Previous study determined five 
deduced antigenic sites on the HA protein, named sites A, 
B, C, D and E, all of which were located in HA1 gene 
(Damiani  et al., 2008). The two Chinese strains, 
Heilongjiang/1/2010 and Heilongjiang/1/2011, differed by 
four AA (S47T, T144A, G158E and G198E), and three of 
which, position 144,158 and 188 were located in deduced 
antigenic sites. Unique amino acid change was found in 
HA1 gene of Heilongjiang/1/10 (A144T, Site A) and 
Heilongjiang/1/11 (G158E, Site B).Meanwhile, unique 
change (E198G, Site B) was found only in 
Heilongjiang/1/11 and Heilongjiang/10/08. Amino acid 
substitution at position 47 (S→T), located outside of the 
five antigenic sites, was regarded as a special genetic 
characteristic of isolates in China (Qi et al., 2010), which 
was observed in Heilongjiang/1/10 again.  
As described in previous research, new drift variants 
subjected to outbreak of influenza had common 
characteristics of four or more than four amino acid 
changes located in two or more than two of the five 
antigenic sites (Daly et al., 2011). The results of 
alignment between new drift variants with vaccine 
reference strains were revealed in Table 2. It can be 
concluded that vaccine containing Richmond/1/07-like 
antigen has better protective effect in China. But such EI 
vaccine has not appeared. 
The most significant cause for 2008 outbreak of 
China is likely to be limited EI vaccination programs. UpPak Vet J, 2013, 33(2): 238-240. 
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Fig. 1: Based on maximum composite likelihood model, a neighbor-joining phylogenetic tree is constructed by HA1 subunit proteins of selected 
thirty-five H3N8 EIVs. The two new isolates are shown in a fixed circle. The strains isolated from 2007-2008 outbreaks in China are indicated by an 
open circle. Vaccine isolates recommended by OIE are indicated by a square. 
 
Table 2: The comparison result of Heilongjiang/1/10 and Heilongjiang/ 
1/11 with vaccine reference isolates in five deduced antigenic sites in 
HA1 subunit protein.    
New isolate 
Heilongjiang/1/2010 Heilongjiang/1/2011 
Vaccine  
reference  
isolate  A B C D E Total* A B C D E Total* 
Newmarket/2/93 1 2 3 2 1  9/5  2 2 3 2 1  10/5 
Newmarket/1/93 - 3 1 - -  4/2  1 3 1 - -  5/3 
Kentucky/1/94  - 3 1 - -  4/2  1 3 1 - -  5/3 
Ohio/1/03  - 2 - - 1  3/2  1 2 - - 1  4/3 
South  Africa/4/03 - 2 - - 1  3/2  1 3 - - 1  5/3 
Richmond/1/07  - 1 - - -  1/1  1 1 - - -  2/2 
*Total indicates: The number of amino acid residue substitutions in five 
deduced antigenic sites/the number of changed deduced antigenic sites. 
 
to date, few horses in China are vaccinated with 
commercially available EI vaccine of none-updated 
recombinant viral vector vaccine ProteqFlu, most of 
which are racehorses. Its components are Kentucky/94 
and Newmarket/2/93(Bryant et al., 2010; Gildea et al., 
2010a). Different from none-updated ProteqFlu, updated 
ProteqFlu contains antigen of the Ohio/03 vaccine strain, 
which has the most closely genetically relationship with 
recent EIV isolates in China among the commercial 
vaccines. Therefore, compared with ProteqFlu, it is 
possible that horses vaccinated with updated ProteqFlu in 
China can achieve a better protective effect.  
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